• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Active Commuters Have Lower Risks for Morbidity, Mortality

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 17, 2024.

WEDNESDAY, July 17, 2024 -- Active commuters who cycle or walk to work have lower risks for morbidity and mortality, according to a study published online July 16 in BMJ Public Health.

Catherine Friel, from the University of Glasgow in the United Kingdom, and colleagues examined prospective associations with multiple health outcomes over 18 years for pedestrians and cyclists using data for 82,297 individuals aged 16 to 74 years from the Scottish Longitudinal Study. Cyclist and pedestrian commuters were compared to nonactive commuters for a range of health outcomes.

The researchers found that cyclist commuting was associated with lower risks for all-cause mortality, any hospitalization, cardiovascular disease (CVD) hospitalization, and having a CVD prescription compared with nonactive commuting (hazard ratios, 0.53, 0.90, 0.76, and 0.70, respectively) and with lower risks for cancer mortality, cancer hospitalization, and having a prescription for mental health problems (hazard ratios, 0.49, 0.76, and 0.80, respectively). Pedestrian commuting was associated with lower risks for any hospitalization, CVD hospitalization, having a CVD prescription, and having a mental health prescription (hazard ratios, 0.91, 0.90, 0.90 and 0.93, respectively).

"These findings provide direct evidence of the health benefits of active commuting in a Scottish context, supporting current policy," the authors write. "This study has wider global relevance to efforts to reduce carbon emissions and to shift to more active and sustainable travel modes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.